TerminatedPhase 3

Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture

Stopped: Case numbers not enough, however, the funding is over

17 participantsStarted 2016-08-08

Plain-language summary

Patients diagnosed traumatic rib fracture and need admission will be included. Patients will be divided two groups.The experimental group will be given parecoxib after visiting emergency department. The control group will be given Narcotic agent such as morphine for pain control. The outcome such as numerical rating scale (NRS) and hospital length of stay will be recorded.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Investigators will prospective enroll patients who are diagnosed chest trauma with rib fractures
✓. Age ≧18 y/o

Exclusion criteria

✕. Patients who have history of heart failure, CAD history.
✕. Traumatic cardiac injury and cardiac tamponade
✕. History of allergy effect for Cyclooxygenase 2 (COX2) inhibitor or NSAID

What they're measuring

all cause mortality

Timeframe: 1 year

Trial details

NCT IDNCT02749409

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-10

View on ClinicalTrials.gov More Parecoxib trials